This article reviews current animal and human data regarding possible adverse fetal effects from antenatal steroid treatment. Although it is now well accetped that such treatment is of benefit to fetal lung development, the potential for adverse fetal outcomes as a result of single or multiple glucocorticoid dosing has not been widely recognized. There are now growing concerns, based on animal and some human data, that repeated antenatal doses could lead to a decrease in birth weight, a decrease in fetal brain and other organ size, and abnormal neuronal development. Previous investigations have been hampered by nonstandardization in the type of glucocorticoid, route of delivery, timing of administration, and number of treatment courses. It is recommended that these concerns be addressed through large randomized, controlled clinical trials. In the meantime, it would be prudent to minimize antenatal steroid treatments to a single course with repeated dosing only if there is a persistent threat of preterm delivery. THe practice of giving weekly injections of steroids starting at fetal viability and continuing into the third trimester is not supported.
1. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics1972;50:515-525.
2.
2. Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol1969;45:515-523.
3.
3. DeLemos RA, Shermeta DW, Knelson JH, Kotas R, Avery ME. Acceleration of appearance of pulmonary surfactant in the fetal lamb by administration of corticosteroids. Am Rev Respir Dis1970;102:459-459.
4.
4. Kotas RV, Avery ME. Accelerrated appearance of pulmonary surfactant in the fetal rabbit. J Appl Physiol1971;30:358-358.
5.
5. Naeye RL, Harcke HT, Blanc WA. Adrenal gland structure and the development of hyaline membrane disease. Pediatrics1971;47:650-650.
6.
6. Ballard RA, Ballard PL, Creasy RK, et al. Respiratory disease in very-low-birth weight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. Lancet1992;339:510-515.
7.
7. Fujiwara T, Maeta H, Chida S, et al. Artificial surfactant therapy in hyaline membrane disease. Lancet1980;i:55-59.
8.
8. Wellmann KF, Volk BW. Fine structural changes in the rabbit placenta induced by cortisone. Arch Pathol1972;94:147-157.
9.
9. Pratt L, Magness RR, Phernetton T, Hendricks SK, Abbott DH, Bird IM. Repeated use of betamethasone in rabbits: Effects of treatment variation on adrenal suppression, pulmonary maturation, and pregnancy outcome. Am J Obstet Gynecol1999;180:1-11.
10.
10. Frank L, Roberts RJ. Effects of low-dose prenatal corticosteroid administration on the premature rate. Biol Neonate1979;36:1-9.
11.
11. DeSouza SW, Adlard BPF. Growth of sucking rats after treatment with dexamethasone or cortisol: Implications for steroid treatment in human infants. Arch Dis Child1973;48:519-522.
12.
12. Barrada MI, Blomquist CH, Kolts C. The effects of betamechasone on fetal development in the rabbit. Am J Obstet Gynecol1980;136:234-238.
13.
13. Sun B, Jobe AH, Ridger E, Ikegami M. Single dose versus two doses of betamethasone for lung maturation in preterm rabbits. Pediatr Res1993;33:256-260.
14.
14. Conley AJ, Bird IM. The role of cytochrome P450 17α-hydroxylase and 3β-hydroxysteroid dehydrogenase in the integration of adrenal and gonadal steroidogenesis via the Δ5 and Δ4 pathways. Biol Reprod1997;56:789-799.
15.
15. Fowden AL, Szemere J, Hughes P, Gilmour RS, Forhead AJ. The effects of cortisol on the growth rate of the sheep fetus during late gestation. J Endocrinol1996;151:97-105.
16.
16. Ikegami M, Jobe AH, Newnham J, Polk DH, Willet KE, Sly P. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med1997;156:178-184.
17.
17. Barker DJ. Fetal origins of cardiovascular disease. Ann Med1999;31Suppl 1:3-6.
18.
18. Quinlivan JA, Archer MA, Dunlop SA, Evans SF, Beazley LD, Newnham JP. Fetal growth retardation, particularly within lymphoid organs, following repeated maternal injections of betamethasone in sheep. J Obstet Gynaecol Res1998;24:173-182.
19.
19. Huang WL, Beazley LD, Quinlivan JA, Evans SF, Newnham JP, Dunlop SA. Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol1999;94:213-218.
20.
20. Dodic M, May CN, Wintour EM, Coghlan JP. An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin Sci1998;94:149-155.
21.
21. Dunlop SA, Archer MA, Quinlivan JA, Beazley LD, Newnham JP. Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. J Matern Fetal Med1997;6:309-313.
22.
22. Uno H, Eisele S, Sakai A, et al. Neurotoxicity of glucocorticoids in the primate brain. Horm Behav1994;28:236-248.
23.
23. Jobe AH, Polk D, Ikegami M, et al. Lung responses to ultrasound-guided fetal treatment with corticosteroids in preterm lambs. J Appl Physiol1993;75:2099-2105.
24.
24. France JT, Magness RR, Murry BA, Rosenfeld CR, Mason JI. The regulation of ovine placental steroid 17α-hydroxylase and aromatase by glucocorticoid. Mol Endocrinol1988;2:193-199.
25.
25. Mason JI, France JT, Magness RR, Murry BA, Rosenfeld CR. Ovine placental steroid 17α-hydroxylase C-17,20-lyase, aromatase and sulphatase in dexamethasone-induced and natural parturition. J Endocrinol1989;122:351-359.
26.
26. Newnham JP, Evans SF, Godfrey ME, Huang WL, Ikegami M, Jobe A. Maternal, but not fetal, administration of corticosteroids restricts fetal growth. J Matern Fetal Med1999;8:81-87.
27.
27. Jobe AH, Wada N, Berry LM, Ikegami M, Ervin MG. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol1998;178:880-885.
28.
28. Jobe AH, Polk DH, Ervin MG, Padbury JF, Rebello CM, Ikegami M. Preterm betamethasone treatment of fetal sheep: Outcome after term delivery. J Soc Gynecol Invest1996;3:250-258.
29.
29. Sumi SM, Truog WE, Kessler DM. Maternal corticosteroid therapy and the fetal brain in experimental hyaline membrane disease. Pediatr Res1984;15:44-45.
30.
30. Castracane VD. The effect of dexamethasone administration at different stages of gestation on maternal plasma steroid concentrations in the baboon (Papio cynocephalus). Hum Reprod1998;13:2282-2285.
31.
31. Kessler DL, Truog WE, Murphy JH, et al. Experimental hyaline membrane disease in the premature monkey: Effects of antenatal dexamethasone. Am Rev Respir Dis1982;126:62-69.
32.
32. Dayer AM, Kapanci Y, Rademakers, Rusy LM, De Mey J, Will JA. Increased numbers of neuroepithelial bodies (NEB) in lungs of fetal rhesus monkeys following maternal dexamethasone treatment. Cell Tissue Res1985;239:703-705.
33.
33. Johnson JW, Mitzner W, London WT, et al. Long-term effects of betamethasone on fetal development. Am J Obstet Gynecol1981;141:1053-1064.
34.
34. Engle MJ, Kemnitz JW, Yao TJ, Perelman RH, Farell PM. Effects of maternal dexamethasone therapy on fetal lung development in the rhesus monkey. Am J Perinatol1996;13:399-407.
35.
35. Novy MJ, Walsh SW. Dexamethasone and estradiol treatment in pregnant rhesus mecaques: Effects on gestational length, maternal plasma hormones, and fetal growth. Am J Obstet Gynecol1983;145:920-931.
36.
36. Coe CL, Kemnitz JW, Schneider ML. Vulnerability of placental antibody transfer and fetal complement synthesis to disturbance of the pregnant monkey. J Med Primatol1993;22:294-300.
37.
37. Coe CL, Lubach GR, Karaszewski J. Effects of prenatal stress on recognition of self and nonself in the primate neonate. Biol Neonate1999;76:301-310.
38.
38. Epstein MF, Farrell PM, Sparks MW, Pepe G, Driscoll SG, Chez RA. Maternal betamethasone and fetal growth and development in the monkey. Am J Obstet Gynecol1977;127:261-263.
39.
39. Johnson JW, Mitzner W, London WT, Palmer AE, Scott R. Betamethasone and the rhesus fetus: Multisystemic effects. AM J Obstet Gynecol1979;133:677-684.
40.
40. Leakey JEA, Althaus ZR, Bailey JR, Slikker W. Dexamethasone induces hepatic cytochrome P-450 Content and increases certain monooxygenase activities in rhesus monkey fetuses. Biochem Pharmacol1986;35:1389-1391.
41.
41. Uno H, Lohmiller L, Thieme C, et al. Brain damage induced by prenatal exposure to decamethasone in fetal rhesus macaques. I. Hippocampus. Dev Brain Res1990;53:157-167.
42.
42. Walsh SW, Norman RL, Novy MJ. In utero regulation of rhesus monkey fetal adrenal. Effects of dexamethasone, adrenocorticotrophin, thyrotropin-releasing hormone, prolactin, human chorionic gonadotropin, and alpha-melanocyte-stimulating hormone on fetal and maternal plasma steroids. Endocrinology1979;104:1805-1813.
43.
43. Challis JRG, Davies IJ, Bernirschke K, et al. The effects of dexamethasone on the peripheral plasma concentration of androstenedione, testosterone, and cortisol in the pregnant rhesus monkey. Endocrinology1975;96:185-192.
44.
44. Ducsay CA, Ervin G, Kaushi KM, Matsumoto T. Myometrial contractile responsiveness to oxytocin after dexamethasone suppression of circadian uterine activity in pregnant rhesus macaques during the gestation. Am J Obstet Gynecol1992;167:1636-1641.
45.
45. Althaus ZR, Bailey JR, Leakey JEA, Slikker W. Transplacental metabolism of dexamethasone and corticol in the late gestational age rhesus monkey (Macaca mulatta)Dev Pharmacol Ther1986;9:332-349.
46.
46. Sawyer R, Hendricks A, Osburn B, Terrel T. Abnormal morphology of the fetal monkey (Macaca mulatta) thymus exposed to a corticosteroid. J Med Primatol1977;6:145-150.
47.
47. Coe CL, Lubach GR. Prenatal influences on neuroimmune set points in infancy. Annal N Y Acad Sci. In press.
48.
48. Gamsu HR, Mullinger BM, Donnai P, Dash CH. Antenatal administrationof betamethasone to prevent respiratory distress syndrome in preterm infants: Report of a UK multicentre trial. Br J Obstet Gynaecol1989;96:401-410.
49.
49. Yunis KA, Bitar FF, Hayek P, Mroueh SM, Mikati M. Transient hypertrophic cardiomyopathy in the newborn following multiple doses of antenatal corticosteroids. AM J Perinatol1999;16:17-21.
50.
50. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. Repeated antenatal corticosteroids: Size at birth and subsequent development. Am J Obstet Gynecol1999;180:114-121.
51.
51. Gennser G, Rymark P, Isberg PE. Low birth weight and risk of high blood pressure in adulthood. BMJ1988;296:1498-1500.
52.
52. Collaborative Group on Antenatal Steroid Therapy. Effect of antenatal steroid administration on the infant: Longterm folluw-up. J Pediatr1984;104:259-267.
54. Smolders-de Haas H, Neuvel J, Schmand B, Treffers PE, Koppe JG, Hoeks J. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: A 10- to 12-year follow-up. Pediatrics1990;86:65-70.
55.
55. Banks BA, Cnaan A, Morgan MA. et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. Am J Obstet Gynecol1999;181:709-717.
56.
56. Salokorpi T, Sajaniemi N, Hallback H, et al. Randomized study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years. Acta Paediatr1997;86:294-298.
57.
57. Howie RN, Liggins GC. The New Zealand study of antepartum glucocorticoid treatment. In: Farrel PM, ed. Lung development. Biological and clinical perspectives. II. New York: Academic Press, 1982;255-265.
58.
58. Papile LA, Stoll B, Donovan E, et al. A multi-center trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med1998;338:1112-1118.
59.
59. O'Shea TM, Kothadia JM, Klinepeter KL, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birthweight infants: Outcome of study participants at 1-year adjusted age. Pediatrics1999;104:15-21.
60.
60. Yeh TF, Lin YJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: A follow-up study. Pediatrics1998;101:E7-E7.
61.
61. Esplin MS, Fausett MB, Smith S, et al. Multiple courses of antenatal steroids are associated with a delay in long-term psychomotor development in children with birth weight < 1,500 grams. AM J Obstet Gynecol2000;182:A27-A27.
62.
62. Bradley BS, Kumar SP, Mehta PN, Ezhathachau SG. Neonatal cushingoid syndrome resulting from serial courses of antenatal betamethasone. Obstet Gynecol1994;83:869-872.
63.
63. Abassi S, Hirsch D, Davis J, et al. Effect of single vs. Multiple courses of antenatal steroids on neonatal outcome. Am J Obstet Gynecol1997;179:A138-A138.
64.
64. Vermillion S, Soper D, Newman R. Neonatal sepsis and death after multiple doses of antenatal betamethasone. Am J Obstet Gynecol2000;182:A28-A28.
65.
65. Ghidini A, Salafia CM, Minior VK. Repeated courses of steroids in preterm membrane rupture do not increase the risk of histologic chorioammionitis. Am J Perinatol1997;14:309-313.
66.
66. Wright LL, Horbar JD, Gunkel H, et al. Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birthweight infants. Am J Obstet Gynecol1995;173:263-269.
67.
67. Wright LL, Verter J, Younes N, et al. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: The NICHD Neonatal Research Network. Am J Obstet Gynecol1995;173:269-274.
68.
68. Horbar JD, for the investigators of the Vermont-Oxford Trials Network. Antenatal corticosteroid treatment and neonatal outcomes for infants 501 to 1500 gm in the Vermont-Oxford Trials Network. Am J Obstet Gynecol1995;173:275-281.
69.
69. Crowley PA. Antenatal corticosteroid therapy: A meta-analysis of the randomized trials. 1972 to 1994. Am J Obstet Gynecol1995;173:322-335.
70.
70. Allen VM, Allen AC, Usher RA, Liston RM. The effect of multiple courses of maternal antenatal steroids on the prevention of complications of prematurity. Am J Obstet Gynecol1997;176:A136-A136.
71.
71. Debbs R, Abbasi S, Tolosa J, Weiner S, Wapner R. Does serial versus single course betamethasone therapy increase neonatal morbidity?Am J Obstet Gynecol1997;179:A130-A130.
72.
72. Cunningham DS, Evans EE. The effects of betamethasone on maternal cellular resistance to infection. Am J Obstet Gynecol1991;165:610-615.
73.
73. Elimian A, Verma U, Visintainer P, Tejani N. Effectiveness of multidose antenatal steroids. Obstet Gynecol2000;95:34-36.
74.
74. Vermillion ST, Soper DE, Chasedunn-Roark J. Neonatal sepsis after betamethasone administration to patients with preterm premature rupture of membranes. Am J Obstet Gynecol1999;181:320-327.
75.
75. Caudle MR, Harbert GM, Singhas CA. Effect of betamethasone on fetal macrophage function: Depression of adherence of immunoglobulin-coated red blood cells. Am J Reprod Immunol1981;1:182-184.
76.
76. Fuenfer MM, Herson VC, Raye JR, et al. The effect of betamethasone on neonatal neutrophil chemotaxis. Pediatr Res1987;22:150-153.
77.
77. Shea C, Morse ED. Inhibition of human neutrophil chemotaxis by corticosteroids. Ann Clin Lab Sci1978;8:30-33.
78.
78. Eisenfeld L, Rosenkrantz TS, Block C, et al. Effects of corticosteroids on the maturation of neutrophil motility in very low birthweight neonates. Am J Perinatol1994;11:163-166.
79.
79. Barak M, Cohen A, Herschkowitz S. Total leukocyte and neutrophil count changes associated with antenatal betamethasone administration in premature infants. Acta Paediatr1992;81:760-763.
